8 reports

  • MARKET OVERVIEW

TUBERCULOSIS Vaccine Mérieux Inactive Rabipur Inactive ADT Booster Infanrix BCG vaccine Source: Technavio VACCINE RECOMMENDATION FOR TRAVELERS FIVE FORCES ANALYSIS FIVE FORCES ANALYSIS Threat of substitutes Moderate In the future, vaccines could provide broader serotype coverage as compared

  • Meningococcal
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • TUBERCULOUS MENINGITIS VACCINE - DRUG PROFILE
  • MENINGITIS - PIPELINE BY SANOFI PASTEUR SA, H2 2016
  • Anti-Infective
  • Infectious Disease
  • Meningococcal
  • Vaccine
  • ContraFect Corporation
  • JN-INTERNATIONAL MEDICAL CORP
  • NEISSERIA MENINGITIDIS INFECTIONS - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2017

JN manufactures diagnostic test kits for malaria, transient ischemic attack, tuberculosis, Alzheimer' s disease and HIV.

  • Meningococcal
  • China
  • United States
  • World
  • Product Initiative
  • NEISSERIA MENINGITIDIS INFECTIONS - PIPELINE BY MGB BIOPHARMA LTD, H1 2017
  • NEISSERIA MENINGITIDIS INFECTIONS - PIPELINE BY JN-INTERNATIONAL MEDICAL CORP, H1 2017

JN manufactures diagnostic test kits for malaria, transient ischemic attack, tuberculosis, Alzheimer' s disease and HIV.

  • Meningococcal
  • Pathology
  • Vaccine
  • United States
  • Product Initiative
  • Clinical Trial Profile Snapshots

Tuberculosis Completed Phase I Interventional rifampin Macleods Pharmaceuticals Ltd ## Jan 2015 ## Dec 2015 DNA Directed RNA Polymerase (POLR## or EC ##. ##. ##. ##) Inhibitor DNA Directed RNA Polymerase (POLR## or EC ##. ##. ##. ##) Trial Title Official Title Clinical Trial profile. ## Trial Title Officia

  • Infectious Disease
  • Meningococcal
  • World
  • Product Initiative
  • Pfizer Inc.
  • VACCINE TO TARGET PKND FOR TUBERCULOUS MENINGITIS - DRUG PROFILE
  • TUBERCULOUS MENINGITIS VACCINE - DRUG PROFILE
  • Meningococcal
  • Pharmaceutical
  • United States
  • Product Initiative
  • ContraFect Corporation

Tuberculosis Diagnosis Of Tuberculosis Aids in detecting the presence of Mycobacterium tuberculosis in patient s sample ELITechGroup Inc Europe In Approval Process Class C CE ELITE INGENIUS RESPIRATORY PANELS REAGENT ELITE INGENIUS RESPIRATORY PANELS REAGENT PRODUCT OVERVI

  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Meningococcal
  • United States
  • ELITECHGROUP INC.
  • Clinical Trial Profile Snapshots

Tuberculosis, Tuberculous Meningitis Ongoing, not recruiting Phase I Interventional rifampin University of California, San Francisco ## Nov 2014 ## Aug 2015 ## ## ## DNA-Dependent RNA Polymerase Inhibitor DNA-Directed RNA Polymerase (EC ##. ##. ##. ##) Clinical Trial profile. ## Trial Title Officia

  • Infectious Disease
  • Meningococcal
  • World
  • Product Initiative
  • Novartis AG